NCT07039695 is a NA clinical trial of Volar buttress plate in Union, sponsored by Helwan University.

Who is sponsoring NCT07039695?

NCT07039695 is sponsored by Helwan University.

What drugs are being tested in NCT07039695?

Interventions in NCT07039695: Volar buttress plate, Herbert screw.

What condition does NCT07039695 study?

NCT07039695 studies Union, Scaphoid, Non-Union Fracture, Herbert Screw, Volar Buttress Plate.

Is NCT07039695 still recruiting?

NCT07039695 is currently completed. Last updated 26 June 2025.

Last reviewed 2025-06-26 · How we verify

NCT07039695

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Union Rate of Scaphoid Non-Union Fracture in Adults by Herbert Screw Versus Volar Buttress Plate

Completed NA Last updated 26 June 2025

What this trial tests

NA trial testing Volar buttress plate in Union in 30 participants. Completed in 1 June 2022.

Timeline

1 March 2020

Primary endpoint
1 June 2022

1 June 2022

Quick facts

Lead sponsor	Helwan University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 March 2020
Primary completion	1 June 2022
Estimated completion	1 June 2022
Sites	1 location across Egypt

Drugs / interventions tested

Volar buttress plate
Herbert screw

Conditions studied

Union — all drugs for Union →
Scaphoid — all drugs for Scaphoid →
Non-Union Fracture — all drugs for Non-Union Fracture →
Herbert Screw — all drugs for Herbert Screw →

Sponsor

Helwan University

Who can join

Adults 20 to 50, any sex, with Union or Scaphoid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to evaluate the short-term results of treating non-united scaphoid waist fractures with a humpback deformity by graft and internal fixation using a volar buttress plate versus the use of a Herbert screw.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Helwan University trials

Trials by the same sponsor.

NCT07342361 — Using Retrograde Intrarenal Surgery for Managing Staghorn Renal Stones. · NA · recruiting
NCT06786507 — A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis · not yet recruiting
NCT06535529 — Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients · Phase 3 · recruiting
NCT07416331 — Impact Of Using LevosemidanVersus DobutamineOn Right Ventricular Function In AdultPatients Undergoing Elective Valve Rep · completed
NCT06884995 — Correlation of Weight Loss With Residual Gastric Volume and Shape on Computerized Tomography in Patients Undergoing Slee · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07039695 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Helwan University
Last refreshed: 26 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07039695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing